


Frédéric de Bure
Frédéric de Bure is a partner in the Paris office of Cleary Gottlieb Steen & Hamilton LLP. He specializes in EU and French competition law, including merger control, cartel investigations, market dominance cases and related litigation matters. He advises clients in complex merger control cases before the European Commission and the French Competition Authority, and represents clients in a number of international cartel/dominance investigations. His experience also includes major competition cases before the European courts in Luxembourg and the French courts. Frédéric de Bure is also widely published on various aspects of EU and French competition law, and lectures competition law at Sciences Po Paris and the University of Montpellier. He is a graduate of Sciences-Po Paris and the London School of Economics.
Distinctions
Linked authors
10947 | Events


Articles
956 Bulletin
254
January 31, 2022 On January 26, 2022, Cleary Gottlieb obtained an important decision from the French Cour de cassation ruling for the first time that internal documents summarizing/forwarding outside counsel’s advice in connection with anticipated litigation are protected by the secret (...)
145
On December 9, 2020, the Court of Justice of the European Union granted Canal+’s application to annul the European Commission’s decision under Article 9 of Regulation No. 1/2003 to adopt commitments offered by Paramount (the “Commitments Decision”). The commitments prohibited Paramount from (...)
557
On October 13, 2020, the European Commission published a call for contributions to determine if and how EU competition policy can better support the European Green Deal. The European Green Deal is a comprehensive action plan aimed at making Europe the world’s first climate neutral continent by (...)
3362 Review
2167
Table of contents: The zombie threat in the post-Covid-19 economy: Competition policy implications, Frédéric de Bure, Partner, Cleary Gottlieb Steen & Hamilton, Paris How can merger control serve de-zombification?, Gönenç Gürkaynak, Founding Partner, ELIG Gürkaynak Attorneys-at-Law, Istanbul (...)
1195
Innovation seems to have become the new mantra among the antitrust community in Europe. In the specific context of merger control, the debate focuses on the possible impact of mergers on classic R&D and whether turnover-based jurisdictional thresholds create a risk that certain harmful (...)